Clinical Trial Update: Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent Tumors [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the effects of age and kidney function on the safety, efficacy, and pharmacokinetics of OctreoScan in patients with new…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• OCTREOSCAN (Indium-111 pentetreotide)

Snippet

Sponsor: Mallinckrodt | Conditions: Solid Tumors | Phase 4 | Status: TERMINATED